TETRAZINE MIT VERBESSERTEN EIGENSCHAFTEN

European patent · EP4572800 · In force

Register entry

Publication number
EP4572800
Application number
EP24706239
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 15, 2024
Published
Jun 25, 2025
Granted
Apr 8, 2026
Protection ends at the latest
Feb 14, 2044
Next annual fee due
Feb 28, 2027
IPC classes
A61K 47/68 (2017.01)
A61K 31/495 (2006.01)
A61K 51/04 (2006.01)
A61P 35/00 (2006.01)
C07D 401/14 (2006.01)
Priority
EP 23156915 15.02.2023
EP 23174627 22.05.2023
EP 23216311 13.12.2023
EP 23216318 13.12.2023
EP 23217256 15.12.2023
EP 23217334 15.12.2023
EP 24153683 24.01.2024
PCT application
PCT/NL2024/050076 15.02.2024
PCT publication
WO2024/172652 22.08.2024
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 01.07.2026

  2. Apr 8, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 08.04.2026

Parties

Holder

Tagworks Pharmaceuticals B.V.

Toernooiveld 1, 6525 ED Nijmegen, NL

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

KLEIJN, Laurens Henri Johan

6525 ED Nijmegen, NL

ROBILLARD, Marc Stefan

6525 ED Nijmegen, NL

ROSSIN, Raffaella

6525 ED Nijmegen, NL

VERSTEEGEN, Ronny Mathieu

6525 ED Nijmegen, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.